Angiogenesis: An update and potential drug approaches (Review)

  • Authors:
    • Maen Abdelrahim
    • Santhi Konduri
    • Md. Riyaz Basha
    • Philip A. Philip
    • Cheryl H. Baker
  • View Affiliations

  • Published online on: January 1, 2010     https://doi.org/10.3892/ijo_00000470
  • Pages: 5-18
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The therapeutic potential of targeting tumor endothelium and vascular supply is now widely recognized to treat different diseases. One such disease is cancer; where endothelial cells are actively proliferating to support the tumor growth. Solid tumors cannot grow beyond the size of a few millimeters without inducing the proliferation of endothelium and formation of new blood vessels. Hence it is crucial to search for new agents that selectively block tumor blood supply. These include anti-angiogenic molecules, vascular disrupting agents or endothelial disrupting agents. The anti-angiogenic molecules such as monoclonal antibodies and tyrosine kinase inhibitors disrupt endothelial cell survival mechanisms and new blood vessel formation, and vascular disrupting agents for instance ligand-directed and small molecules can be used to disrupt the already existing abnormal vasculature that support tumors by targeting their dysmorphic endothelial cells. The recent advances in this area of research have identified a variety of investigational agents which are currently in clinical development at various stages and some of these candidates are already approved in cancer treatment. This report will review some of the recent developments and most significant advances in this field and outline future challenges and directions.

Related Articles

Journal Cover

January 2010
Volume 36 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Abdelrahim, M., Konduri, S., Riyaz Basha, M., Philip, P.A., & Baker, C.H. (2010). Angiogenesis: An update and potential drug approaches (Review). International Journal of Oncology, 36, 5-18. https://doi.org/10.3892/ijo_00000470
MLA
Abdelrahim, M., Konduri, S., Riyaz Basha, M., Philip, P. A., Baker, C. H."Angiogenesis: An update and potential drug approaches (Review)". International Journal of Oncology 36.1 (2010): 5-18.
Chicago
Abdelrahim, M., Konduri, S., Riyaz Basha, M., Philip, P. A., Baker, C. H."Angiogenesis: An update and potential drug approaches (Review)". International Journal of Oncology 36, no. 1 (2010): 5-18. https://doi.org/10.3892/ijo_00000470